| Bioactivity | DD202-114 is a potent and selective GLP1R agonist. DD202-114 promots cAMP accumulation. DD202-114 reduces blood glucose levels and food intake. DD202-114 has the potential for the research of type 2 diabetes (T2DM) and obesity[1]. |
| Target | GLP1R |
| CAS | 2886728-09-0 |
| Formula | C33H35FN4O5 |
| Molar Mass | 586.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang Z, et al. Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor. J Med Chem. 2024 Sep 12;67(17):14820-14839. |
DD202-114
CAS: 2886728-09-0 F: C33H35FN4O5 W: 586.65
DD202-114 is a potent and selective GLP1R agonist. DD202-114 promots cAMP accumulation. DD202-114 reduces blood glucose
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.